Bonneau, Marion http://orcid.org/0000-0003-4563-7630
Sullivan, Shane T. O’
Gonzalez-Lozano, Miguel A. http://orcid.org/0000-0002-7837-151X
Baxter, Paul
Gautier, Phillippe
Marchisella, Elena
Hardingham, Neil R.
Chesters, Robert A.
Torrance, Helen
Howard, David M. http://orcid.org/0000-0002-6005-1972
Jansen, Maurits A. http://orcid.org/0000-0002-7077-0188
McMillan, Melanie
Singh, Yasmin
Didier, Michel
Koopmans, Frank http://orcid.org/0000-0002-4973-5732
Semple, Colin A.
McIntosh, Andrew M. http://orcid.org/0000-0002-0198-4588
Volkmer, Hansjürgen
Loos, Maarten
Fox, Kevin http://orcid.org/0000-0002-2563-112X
Hardingham, Giles E.
Vernon, Anthony C. http://orcid.org/0000-0001-7305-1069
Porteous, David J. http://orcid.org/0000-0003-1249-6106
Smit, August B.
Price, David J.
Kirsty Millar, J.
Article History
Received: 7 March 2020
Revised: 24 November 2020
Accepted: 22 January 2021
First Online: 19 February 2021
Change Date: 20 March 2021
Change Type: Update
Change Details: In the original article, some data sets were missing. They are supporting documents to the supplementary material.
Conflict of interest
: The authors declare that they have no conflict of interests. A.M.M. has received research support from Eli Lilly and Company, Janssen and the Sackler Trust and speaker fees from Illumina and Janssen. A.C.V. has received research support from F. Hoffman La Roche and UCB Biopharma SPRL. M.L. is a full-time employee of Sylics (Synaptologics B.V.), a private company that offers mouse phenotyping services. A.B.S. is a shareholder of Alea Biotech B.V., a holding of Sylics (Synaptologics B.V.). M.D. is based at Sanofi.